Pseudobulbar Affect
Links shared publicly online about this topic
Nuedexta approved for pseudobulbar affect - ONA
oncologynurseadvisor.com — “Avanir Pharmaceuticals announced that the FDA has approved Nuedexta (dextromethorphan hydrobromide and quinidine sulfate capsules) for the treatment of pseudobulbar affect (PBA).” View full resource at oncologynurseadvisor.com
Most Recently Shared on November 1, 2010 at 3:56 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Nuedexta approved for pseudobulbar affect http://goo.gl/fb/R1BMQ
Nuedexta available for pseudobulbar affect - MPR
empr.com — “Avanir announced that Nuedexta (dextromethorphan hydrobromide and quinidine sulfate capsules) is now available for the treatment of pseudobulbar affect.” View full resource at empr.com
Most Recently Shared on January 31, 2011 at 4:18 pm By:
MPR News: Nuedexta available for pseudobulbar affect: Avanir announced that Nuedexta (dextromethorphan hydrobrom... http://bit.ly/hiWN7V
Nuedexta Approved For Uncontrollable Laughing Or Crying (Pseudobulbar Affect)
medicalnewstoday.com — “Nuedexta (dextromethorphan hydrobromide and quinidine sulfate) has been approved in capsule form by the Food and Drug Administration (FDA) as the first line of treatment for uncontrolled laughing” View full resource at medicalnewstoday.com
Most Recently Shared on October 30, 2010 at 5:37 pm By:
Nuedexta Approved For Uncontrollable Laughing Or Crying (Pseudobulbar Affect) Nuedexta (dextromethorphan hydrobromide a.. http://dld.bz/4nh6
AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription
news-medical.net — “AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).” View full resource at news-medical.net
Most Recently Shared on February 1, 2011 at 7:30 am By:
Parkinson's Disease: AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription: AVANIR Pharmaceuti... http://bit.ly/f8tsV5
Dextromethorphan/quinidine for pseudobulbar affect — Current Psychiatry Online
currentpsychiatry.com — “Dextromethorphan/quinidine for pseudobulbar affect — Current Psychiatry Online” View full resource at currentpsychiatry.com
Most Recently Shared on February 24, 2011 at 12:57 pm By:
Current Psychiatry Psychiatry and Medical Journal
Out of the Pipeline: Dextromethorphan/quinidine for pseudobulbar affect http://bit.ly/hiRL2P #pseudobulbar #PBA
Involuntary Laughing, Crying Disorder Pseudobulbar Affect - ABC News
abcnews.go.com — “Involuntary laughter, crying of pseudobulbar affect interfere with work, relationships. Patients, doctors welcome FDA approval of first-ever medication for disorder. Nuedexta capsules improve quality of life.” View full resource at abcnews.go.com
Most Recently Shared on November 4, 2010 at 10:45 pm By:
Susan Scroggins Active Health Library and Health Advocate
When You Can't Stop Laughing, or Crying: Involuntary laughter, crying of pseudobulbar affect interfere with work... http://bit.ly/9nrT3P
Avanir Pharmaceuticals Announces Landmark 'PRISM' Pseudobulbar Affect Patient Registry
medicalnewstoday.com — “Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced the PRISM patient registry, the first patient registry to further quantify the prevalence and quality of life impact of pseudobulbar aff” View full resource at medicalnewstoday.com
Most Recently Shared on May 4, 2011 at 5:05 pm By:
MNT Neurology News Neurology and Health News
Avanir Pharmaceuticals Announces Landmark 'PRISM' Pseudobulbar Affect Patient Registry http://mnt.to/3Vqj #neurology
Not All Crying Is Depression: Understanding Pseudobulbar Affect | Psychology Today
psychologytoday.com — “Many diagnosed with depression suffer from a different, treatable disorder By David DiSalvo...” View full resource at psychologytoday.com
Most Recently Shared on October 18, 2011 at 7:33 pm By:
Psychology Today Health Magazine
"Many people diagnosed with depression suffer from a different, treatable disorder." says David DiSalvo http://t.co/OMoBpchS
Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect
news-medical.net — “Avanir Pharmaceuticals, Inc. announced today that it has submitted an application to the European Medicines Agency seeking marketing authorization for NUEDEXTA (dextromethorphan HBr and quinidine sulfate) for the treatment of pseudobulbar affect.” View full resource at news-medical.net
Most Recently Shared on October 31, 2011 at 2:13 pm By:
Alzheimers News: Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect: Avanir Phar... http://t.co/j9s5KxDx
Pseudobulbar affect impacts majority of stroke survivors, but few have any understanding of condition
news-medical.net — “A survey released today by National Stroke Association shows that 53 percent of stroke survivor respondents suffer from symptoms of another neurologic condition called pseudobulbar affect (PBA), a condition thought to be caused by structural damage in the brain due to injury or disease. PBA causes involuntary and unpredictable outbursts of laughing or crying, often in socially inappropriate situations. Even though a significant proportion of stroke survivors suffer from PBA, fewer than one in fi” View full resource at news-medical.net
Most Recently Shared on October 19, 2010 at 4:06 pm By:
Stroke News: Pseudobulbar affect impacts majority of stroke survivors, but few have any understanding of conditi... http://twurl.nl/6ppxsh
New Drug Approved For Emotional Incontinence : NPR
npr.org — “Pseudobulbar affect, or emotional incontinence, causes uncontrollable laughing and crying. It can be a debilitating side effect of multiple sclerosis, ALS or brain injuries. The Food and Drug Administration has approved the first drug that may help.” View full resource at npr.org
Most Recently Shared on November 2, 2010 at 1:54 am By:
New Drug Approved For Emotional Incontinence: Pseudobulbar affect, or emotional incontinence, causes uncontrollable ... http://n.pr/bsmpxb
Avanir Pharmaceuticals Announces FDA Approval of Nuedexta
drugs.com — “Nuedexta (dextromethorphan hydrobromide and quinidine sulfate) is used to treat pseudobulbar affect. Includes Nuedexta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 2, 2010 at 6:41 am By:
Avanir Pharmaceuticals Announces FDA Approval of Nuedexta - http://bit.ly/czapU6
Avanir Pharmaceuticals Announces Phase III STAR Trial Results Published in Annals of Neurology - Drugs.com MedNews
drugs.com — “AVANIR Pharmaceuticals Announces Phase III STAR Trial Results Published in Annals of Neurology AVANIR Pharmaceuticals, Inc. (Nasdaq AVNR) today announced the el” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 2:17 pm By:
Drugs and Devices OW OW Health
Avanir Pharmaceuticals Announces Phase III STAR Trial Results Published in Annals of Neurology: AVANIR Pharma... http://bit.ly/bY1VxC #drug
U.S. FDA approves Avanir involuntary emotion drug - Health - msnbc.com
msnbc.msn.com — “* FDA OKs first product to treat pseudobulbar affect” View full resource at msnbc.msn.com
Most Recently Shared on October 29, 2010 at 11:37 pm By:
msnbc.com - Health Health News
U.S. FDA approves Avanir involuntary emotion drug http://bit.ly/9cCJdi
AVANIR Pharmaceuticals Announces Phase III STAR Trial Results Published In Annals Of Neurology
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/qu” View full resource at medicalnewstoday.com
Most Recently Shared on September 15, 2010 at 1:32 pm By:
AVANIR Pharmaceuticals Announces Phase III STAR Trial Results Published In Annals Of Neurology http://mnt.to/3JMb #multiplesclerosis
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
medical_tweets
Advertisement
